Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) |
Date |
Article Title | Journal |
|---|---|---|---|
|
Daniel Caldeira, Beatriz Nogueira-Garcia, Ana Abreu & Fausto J. Pinto |
December 2022 | Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort | European Journal of Clinical Nutrition |
|
Yifei Sun, Xuming He, Jianhua Hu |
December 2022 | An omnibus test for detection of subgroup treatment effects via data partitioning | Annals of Applied Statistics |
|
Saskia Litière, Jan Bogaerts |
November 2022 | Imaging endpoints for clinical trial use: a RECIST perspective | Journal for ImmunoTherapy of Cancer |
|
Quentin Le Coënt, Catherine Legrand, Virginie Rondeau |
November 2022 | Time-to-event surrogate endpoint validation using mediation analysis and meta-analytic data | Biostatistics |
|
Austin L. Johnson, Michael Anderson, Max Bouvette, Israel Pinero, Shelby Rauh, Bradley Johnson, Micah Kee, Benjamin Heigle, Andrea C. Tricco, Matthew J. Page, Patti McCall Wright, Matt Vassar |
November 2022 | Clinical Trial Data-sharing Policies Among Journals, Funding Agencies, Foundations, and Other Professional Organizations: A Scoping Review | Journal of Clinical Epidemiology |
|
Celine Yeh, Mengxi Zhou, Keith Sigel, Gayle Jameson, Ruth White, Rachael Safyan, Yvonne Saenger, Elizabeth Hecht, John Chabot, Stephen Schreibman, Béata Juzyna, Marc Ychou, Thierry Conroy, Tito Fojo, Gulam A Manji, Daniel Von Hoff, Susan E Bates |
November 2022 | Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data | The Oncologist |
|
Jian-Sin Lee, Wei Jeng |
October 2022 | Integrated but Isolated: Implications from a Systematic Review of the Access Control Ecosystem for Individual Participant Data in Clinical Studies | John Wiley & Sons, Ltd (asis&t) |
|
Zihang Zhong, Min Yang,Senmiao Ni, Lixin Cai,Jingwei Wu, Jianling Bai |
October 2022 | The heterogeneity effect of surveillance intervals on progression free survival | Journal of Applied Statistics |
|
Khaled El Emam, Lucy Mosquera, Xi Fang |
October 2022 | Validating a membership disclosure metric for synthetic health data | Jamia Open |
|
J. C. Angulo, J. P. Ciria Santos, A. Gómez-Caamaño, R. Poza de Celis, J. L. González Sala, J. M. García Garzón, J. A. Galán-Llopis, M. Pérez Sampietro, V. Perrot & J. Planas Morin on behalf of ANARESISTANCE study group |
September 2022 | Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study | SpringerLink |
|
Qiyu Wang, Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J. Sullivan, Genevieve M. Boland, Kerry L. Reynolds, Meghan E. Sise |
August 2022 | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma | ScienceDirect |
|
Amita Puranik, Prajakta Dandekar, Ratnesh Jain |
August 2022 | Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals | AIChE Biotechnology Progress |
|
Gerd Rippin, Nicolás Ballarini, Héctor Sanz, Joan Largent, Chantal Quinten & Francesco Pignatti |
July 2022 | A Review of Causal Inference for External Comparator Arm Studies | Springer Nature Switzerland AG |
|
Daniele Modonutti MD,Sami E. Majdalany MD,Nicholas Corsi BS,Pin Li PhD,Akshay Sood MD,Deepansh Dalela MD,Marcus L. Jamil MD,Clara Hwang MD,Mani Menon MD,Craig G. Rogers MD,Quoc-Dien Trinh MD,Giacomo Novara MD,Firas Abdollah MD |
July 2022 | A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis | The Prostate |
